Optimal use of ivig in a patient with Behçet syndrome and common variable immunodeficiency.
Brandon
B
Shutty
Kittu Jindal
KJ
Garg
David
D
Swender
Leah
L
Chernin
Haig
H
Tcheurekdjian
Robert
R
Hostoffer
D001528:Behcet Syndrome / Q000150:complications / Q000276:immunology / Q000628:therapy*; D017074:Common Variable Immunodeficiency / Q000150:complications / Q000628:therapy*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000097:blood; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008875:Middle Aged; D016896:Treatment Outcome
D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous